Why the study?
What are the pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam in patients with essential hypertension?
Population
10 patients with essential hypertension
Design
Other
Authors
Loading...
Fenoldopam infusion supports predictable BP titration via log-linear PK/PD; leaves open comparative efficacy versus standard agents in acute hypertension.
What are the pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam in patients with essential hypertension?
Intravenous fenoldopam has a rapid onset of action, short elimination half-life, and linear dose-response relationship, suggesting utility for parenteral treatment of hypertension.
Rr et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: